 | • レポートコード：20QY06-02997 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ヒドロキシカルバミドのグローバル市場について種類別（カプセル、タブレット）、用途別（鎌状赤血球症、がん、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ヒドロキシカルバミド市場の概要 ・世界の主要地域別ヒドロキシカルバミド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒドロキシカルバミド市場規模2015-2026：種類別（カプセル、タブレット） ・世界のヒドロキシカルバミド市場規模2015-2026：用途別（鎌状赤血球症、がん、その他） ・ヒドロキシカルバミドの北米市場規模2015-2020 ・ヒドロキシカルバミドのヨーロッパ市場規模2015-2020 ・ヒドロキシカルバミドの中国市場規模2015-2020 ・ヒドロキシカルバミドの日本市場規模2015-2020 ・ヒドロキシカルバミドの東南アジア市場規模2015-2020 ・ヒドロキシカルバミドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bristol Myers Squibb、Taj Pharma、Beijing Jialin Pharma、Qilu Pharmaceutical、Teva Pharma、Cipla、Zydus Cadila、United Biotech、Par Pharma、Khandelwal Laboratories、Alkem (Cytomed)、Samarth Pharma、VHB Life Sciences） ・ヒドロキシカルバミドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒドロキシカルバミドの市場動向・機会・課題 ・調査の結論 |
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.
The classification of Hydroxycarbamide includes capsule and tablet, and the proportion of capsule in 2016 is about 63%, and the proportion is in decreasing trend from 2012 to 2016.
Hydroxycarbamide is widely used for sickle cell disease, cancer and other disease. The most proportion of Hydroxycarbamide is used for sickle cell disease, and the proportion in 2016 is 45%.
Asia Pacific is the largest supplier of Hydroxycarbamide, with a production market share nearly 59% in 2016.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 36% in 2016. Following Middle East and Africa, Asia Pacific is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech, Par Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Hydroxycarbamide Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hydroxycarbamide market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hydroxycarbamide industry.
Based on our recent survey, we have several different scenarios about the Hydroxycarbamide YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 210.5 million in 2019. The market size of Hydroxycarbamide will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Hydroxycarbamide Scope and Market Size
The global Hydroxycarbamide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hydroxycarbamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hydroxycarbamide market is segmented into
Capsule
Tablet
Segment by Application, the Hydroxycarbamide market is segmented into
Sickle Cell Disease
Cancer
Other
The Hydroxycarbamide market is analysed and market size information is provided by regions (countries). Segment by Application, the Hydroxycarbamide market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hydroxycarbamide Market Share Analysis
Hydroxycarbamide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hydroxycarbamide business, the date to enter into the Hydroxycarbamide market, Hydroxycarbamide product introduction, recent developments, etc.
The major vendors covered:
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences
1 Hydroxycarbamide Market Overview
1.1 Hydroxycarbamide Product Scope
1.2 Hydroxycarbamide Segment by Type
1.2.1 Global Hydroxycarbamide Sales by Type (2020-2026)
1.2.2 Capsule
1.2.3 Tablet
1.3 Hydroxycarbamide Segment by Application
1.3.1 Global Hydroxycarbamide Sales Comparison by Application (2020-2026)
1.3.2 Sickle Cell Disease
1.3.3 Cancer
1.3.4 Other
1.4 Hydroxycarbamide Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hydroxycarbamide Sales Growth Rate (2015-2026)
1.4.2 Global Hydroxycarbamide Revenue and Growth Rate (2015-2026)
1.4.3 Global Hydroxycarbamide Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Hydroxycarbamide Industry Impact
1.5.1 How the Covid-19 is Affecting the Hydroxycarbamide Industry
1.5.1.1 Hydroxycarbamide Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Hydroxycarbamide Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Hydroxycarbamide Players to Combat Covid-19 Impact
2 Hydroxycarbamide Estimate and Forecast by Region
2.1 Global Hydroxycarbamide Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hydroxycarbamide Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hydroxycarbamide Sales Market Share by Region (2015-2020)
2.2.2 Global Hydroxycarbamide Revenue Market Share by Region (2015-2020)
2.3 Global Hydroxycarbamide Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hydroxycarbamide Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hydroxycarbamide Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hydroxycarbamide Estimates and Projections (2015-2026)
2.4.2 Europe Hydroxycarbamide Estimates and Projections (2015-2026)
2.4.3 China Hydroxycarbamide Estimates and Projections (2015-2026)
2.4.4 Japan Hydroxycarbamide Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hydroxycarbamide Estimates and Projections (2015-2026)
2.4.6 India Hydroxycarbamide Estimates and Projections (2015-2026)
3 Global Hydroxycarbamide Competition Landscape by Players
3.1 Global Top Hydroxycarbamide Players by Sales (2015-2020)
3.2 Global Top Hydroxycarbamide Players by Revenue (2015-2020)
3.3 Global Hydroxycarbamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxycarbamide as of 2019)
3.4 Global Hydroxycarbamide Average Price by Company (2015-2020)
3.5 Manufacturers Hydroxycarbamide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hydroxycarbamide Players (Opinion Leaders)
4 Global Hydroxycarbamide Market Size by Type
4.1 Global Hydroxycarbamide Historic Market Review by Type (2015-2020)
4.1.1 Global Hydroxycarbamide Sales Market Share by Type (2015-2020)
4.1.2 Global Hydroxycarbamide Revenue Market Share by Type (2015-2020)
4.1.3 Global Hydroxycarbamide Price by Type (2014-2020)
4.2 Global Hydroxycarbamide Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hydroxycarbamide Sales Forecast by Type (2021-2026)
4.2.2 Global Hydroxycarbamide Revenue Forecast by Type (2021-2026)
4.2.3 Global Hydroxycarbamide Price Forecast by Type (2021-2026)
5 Global Hydroxycarbamide Market Size by Application
5.1 Global Hydroxycarbamide Historic Market Review by Application (2015-2020)
5.1.1 Global Hydroxycarbamide Sales Market Share by Application (2015-2020)
5.1.2 Global Hydroxycarbamide Revenue Market Share by Application (2015-2020)
5.1.3 Global Hydroxycarbamide Price by Application (2015-2020)
5.2 Global Hydroxycarbamide Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hydroxycarbamide Sales Forecast by Application (2021-2026)
5.2.2 Global Hydroxycarbamide Revenue Forecast by Application (2021-2026)
5.2.3 Global Hydroxycarbamide Price Forecast by Application (2021-2026)
3 North America Hydroxycarbamide Market Facts & Figures
3.2 North America Hydroxycarbamide Sales Market Share by Company (2015-2020)
3.3 North America Hydroxycarbamide Sales Market Share by Type (2015-2020)
3.4 North America Hydroxycarbamide Sales Market Share by Application (2015-2020)
4 Europe Hydroxycarbamide Market Facts & Figures
4.2 Europe Hydroxycarbamide Sales Market Share by Company (2015-2020)
4.3 Europe Hydroxycarbamide Sales Market Share by Type (2015-2020)
4.4 Europe Hydroxycarbamide Sales Market Share by Application (2015-2020)
5 China Hydroxycarbamide Market Facts & Figures
5.2 China Hydroxycarbamide Sales Market Share by Company (2015-2020)
5.3 China Hydroxycarbamide Sales Market Share by Type (2015-2020)
5.4 China Hydroxycarbamide Sales Market Share by Application (2015-2020)
6 Japan Hydroxycarbamide Market Facts & Figures
6.2 Japan Hydroxycarbamide Sales Market Share by Company (2015-2020)
6.3 Japan Hydroxycarbamide Sales Market Share by Type (2015-2020)
6.4 Japan Hydroxycarbamide Sales Market Share by Application (2015-2020)
7 Southeast Asia Hydroxycarbamide Market Facts & Figures
7.2 Southeast Asia Hydroxycarbamide Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Hydroxycarbamide Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Hydroxycarbamide Sales Market Share by Application (2015-2020)
8 India Hydroxycarbamide Market Facts & Figures
8.2 India Hydroxycarbamide Sales Market Share by Company (2015-2020)
8.3 India Hydroxycarbamide Sales Market Share by Type (2015-2020)
8.4 India Hydroxycarbamide Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Hydroxycarbamide Business
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Hydroxycarbamide Corporation Information
12.1.2 Bristol Myers Squibb Hydroxycarbamide Business Overview and Total Revenue
12.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bristol Myers Squibb Hydroxycarbamide Products Offered
12.1.5 Bristol Myers Squibb Recent Development
12.2 Taj Pharma
12.2.1 Taj Pharma Hydroxycarbamide Corporation Information
12.2.2 Taj Pharma Hydroxycarbamide Business Overview and Total Revenue
12.2.3 Taj Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Taj Pharma Hydroxycarbamide Products Offered
12.2.5 Taj Pharma Recent Development
12.3 Beijing Jialin Pharma
12.3.1 Beijing Jialin Pharma Hydroxycarbamide Corporation Information
12.3.2 Beijing Jialin Pharma Hydroxycarbamide Business Overview and Total Revenue
12.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Beijing Jialin Pharma Hydroxycarbamide Products Offered
12.3.5 Beijing Jialin Pharma Recent Development
12.4 Qilu Pharmaceutical
12.4.1 Qilu Pharmaceutical Hydroxycarbamide Corporation Information
12.4.2 Qilu Pharmaceutical Hydroxycarbamide Business Overview and Total Revenue
12.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Qilu Pharmaceutical Hydroxycarbamide Products Offered
12.4.5 Qilu Pharmaceutical Recent Development
12.5 Teva Pharma
12.5.1 Teva Pharma Hydroxycarbamide Corporation Information
12.5.2 Teva Pharma Hydroxycarbamide Business Overview and Total Revenue
12.5.3 Teva Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Pharma Hydroxycarbamide Products Offered
12.5.5 Teva Pharma Recent Development
12.6 Cipla
12.6.1 Cipla Hydroxycarbamide Corporation Information
12.6.2 Cipla Hydroxycarbamide Business Overview and Total Revenue
12.6.3 Cipla Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Cipla Hydroxycarbamide Products Offered
12.6.5 Cipla Recent Development
12.7 Zydus Cadila
12.7.1 Zydus Cadila Hydroxycarbamide Corporation Information
12.7.2 Zydus Cadila Hydroxycarbamide Business Overview and Total Revenue
12.7.3 Zydus Cadila Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Zydus Cadila Hydroxycarbamide Products Offered
12.7.5 Zydus Cadila Recent Development
12.8 United Biotech
12.8.1 United Biotech Hydroxycarbamide Corporation Information
12.8.2 United Biotech Hydroxycarbamide Business Overview and Total Revenue
12.8.3 United Biotech Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.8.4 United Biotech Hydroxycarbamide Products Offered
12.8.5 United Biotech Recent Development
12.9 Par Pharma
12.9.1 Par Pharma Hydroxycarbamide Corporation Information
12.9.2 Par Pharma Hydroxycarbamide Business Overview and Total Revenue
12.9.3 Par Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Par Pharma Hydroxycarbamide Products Offered
12.9.5 Par Pharma Recent Development
12.10 Khandelwal Laboratories
12.10.1 Khandelwal Laboratories Hydroxycarbamide Corporation Information
12.10.2 Khandelwal Laboratories Hydroxycarbamide Business Overview and Total Revenue
12.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Khandelwal Laboratories Hydroxycarbamide Products Offered
12.10.5 Khandelwal Laboratories Recent Development
12.11 Alkem (Cytomed)
12.11.1 Alkem (Cytomed) Hydroxycarbamide Corporation Information
12.11.2 Alkem (Cytomed) Hydroxycarbamide Business Overview and Total Revenue
12.11.3 Alkem (Cytomed) Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Alkem (Cytomed) Hydroxycarbamide Products Offered
12.11.5 Alkem (Cytomed) Recent Development
12.12 Samarth Pharma
12.12.1 Samarth Pharma Hydroxycarbamide Corporation Information
12.12.2 Samarth Pharma Hydroxycarbamide Business Overview and Total Revenue
12.12.3 Samarth Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Samarth Pharma Hydroxycarbamide Products Offered
12.12.5 Samarth Pharma Recent Development
12.13 VHB Life Sciences
12.13.1 VHB Life Sciences Hydroxycarbamide Corporation Information
12.13.2 VHB Life Sciences Hydroxycarbamide Business Overview and Total Revenue
12.13.3 VHB Life Sciences Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
12.13.4 VHB Life Sciences Hydroxycarbamide Products Offered
12.13.5 VHB Life Sciences Recent Development
13 Hydroxycarbamide Manufacturing Cost Analysis
13.1 Hydroxycarbamide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hydroxycarbamide
13.4 Hydroxycarbamide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hydroxycarbamide Distributors List
14.3 Hydroxycarbamide Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hydroxycarbamide Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Hydroxycarbamide Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Hydroxycarbamide Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Hydroxycarbamide Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Hydroxycarbamide Players to Combat Covid-19 Impact
Table 8. Global Market Hydroxycarbamide Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Hydroxycarbamide Sales (M Units) by Region (2015-2020)
Table 10. Global Hydroxycarbamide Sales Market Share by Region (2015-2020)
Table 11. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Hydroxycarbamide Revenue Share by Region (2015-2020)
Table 13. Global Hydroxycarbamide Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Hydroxycarbamide Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Hydroxycarbamide Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Hydroxycarbamide Revenue Share Forecast by Region (2021-2026)
Table 17. Global Hydroxycarbamide (M Units) of Key Companies (2015-2020)
Table 18. Global Hydroxycarbamide Sales Share by Company (2015-2020)
Table 19. Global Hydroxycarbamide Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Hydroxycarbamide Revenue Share by Company (2015-2020)
Table 21. Global Hydroxycarbamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxycarbamide as of 2019)
Table 22. Global Hydroxycarbamide Average Price (USD/K Unit) of Key Company (2015-2020)
Table 23. Manufacturers Hydroxycarbamide Manufacturing Sites and Area Served
Table 24. Manufacturers Hydroxycarbamide Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Hydroxycarbamide Players
Table 27. Global Hydroxycarbamide Sales (M Units) by Type (2015-2020)
Table 28. Global Hydroxycarbamide Sales Share by Type (2015-2020)
Table 29. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Hydroxycarbamide Price (M Units) by Type (2015-2020)
Table 31. Global Hydroxycarbamide Sales Share by Type (2021-2026)
Table 32. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Hydroxycarbamide Revenue Share by Type (2021-2026)
Table 34. Global Hydroxycarbamide Price (M Units) by Type (2021-2026)
Table 35. Global Hydroxycarbamide Sales (M Units) by Application (2015-2020)
Table 36. Global Hydroxycarbamide Sales Share by Application (2015-2020)
Table 37. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Hydroxycarbamide Price (M Units) by Application (2015-2020)
Table 39. Global Hydroxycarbamide Sales (M Units) by Application (2021-2026)
Table 40. Global Hydroxycarbamide Sales Share by Application (2021-2026)
Table 41. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Hydroxycarbamide Revenue Share by Application (2021-2026)
Table 43. Global Hydroxycarbamide Price (M Units) by Application (2021-2026)
Table 44. United States Hydroxycarbamide Sales (M Units) by Company (2015-2020)
Table 45. United States Hydroxycarbamide Sales Market Share by Company (2015-2020)
Table 46. United States Hydroxycarbamide Sales (M Units) by Type (2015-2020)
Table 47. United States Hydroxycarbamide Sales Market Share by Type (2015-2020)
Table 48. United States Hydroxycarbamide Sales (M Units) by Application (2015-2020)
Table 49. United States Hydroxycarbamide Sales Market Share by Application (2015-2020)
Table 50. Europe Hydroxycarbamide Sales (M Units) by Company (2015-2020)
Table 51. Europe Hydroxycarbamide Sales Market Share by Company (2015-2020)
Table 52. Europe Hydroxycarbamide Sales (M Units) by Type (2015-2020)
Table 53. Europe Hydroxycarbamide Sales Market Share by Type (2015-2020)
Table 54. Europe Hydroxycarbamide Sales (M Units) by Application (2015-2020)
Table 55. Europe Hydroxycarbamide Sales Market Share by Type (2015-2020)
Table 56. China Hydroxycarbamide Sales (M Units) by Company (2015-2020)
Table 57. China Hydroxycarbamide Sales Market Share by Company (2015-2020)
Table 58. China Hydroxycarbamide Sales (M Units) by Type (2015-2020)
Table 59. China Hydroxycarbamide Sales Market Share by Type (2015-2020)
Table 60. China Hydroxycarbamide Sales (M Units) by Application (2015-2020)
Table 61. China Hydroxycarbamide Sales Market Share by Application (2015-2020)
Table 62. Japan Hydroxycarbamide Sales (M Units) by Company (2015-2020)
Table 63. Japan Hydroxycarbamide Sales Market Share by Company (2015-2020)
Table 64. Japan Hydroxycarbamide Sales (M Units) by Type (2015-2020)
Table 65. Japan Hydroxycarbamide Sales Market Share by Type (2015-2020)
Table 66. Japan Hydroxycarbamide Sales (M Units) by Application (2015-2020)
Table 67. Japan Hydroxycarbamide Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Hydroxycarbamide Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Hydroxycarbamide Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Hydroxycarbamide Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Hydroxycarbamide Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Hydroxycarbamide Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Hydroxycarbamide Sales Market Share by Application (2015-2020)
Table 74. India Hydroxycarbamide Sales (M Units) by Company (2015-2020)
Table 75. India Hydroxycarbamide Sales Market Share by Company (2015-2020)
Table 76. India Hydroxycarbamide Sales (M Units) by Type (2015-2020)
Table 77. India Hydroxycarbamide Sales Market Share by Type (2015-2020)
Table 78. India Hydroxycarbamide Sales (M Units) by Application (2015-2020)
Table 79. India Hydroxycarbamide Sales Market Share by Application (2015-2020)
Table 80. Bristol Myers Squibb Corporation Information
Table 81. Bristol Myers Squibb Description and Business Overview
Table 82. Bristol Myers Squibb Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 83. Bristol Myers Squibb Hydroxycarbamide Product
Table 84. Bristol Myers Squibb Recent Development
Table 85. Taj Pharma Corporation Information
Table 86. Taj Pharma Description and Business Overview
Table 87. Taj Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 88. Taj Pharma Hydroxycarbamide Product
Table 89. Taj Pharma Recent Development
Table 90. Beijing Jialin Pharma Corporation Information
Table 91. Beijing Jialin Pharma Description and Business Overview
Table 92. Beijing Jialin Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 93. Beijing Jialin Pharma Hydroxycarbamide Product
Table 94. Beijing Jialin Pharma Recent Development
Table 95. Qilu Pharmaceutical Corporation Information
Table 96. Qilu Pharmaceutical Description and Business Overview
Table 97. Qilu Pharmaceutical Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 98. Qilu Pharmaceutical Hydroxycarbamide Product
Table 99. Qilu Pharmaceutical Recent Development
Table 100. Teva Pharma Corporation Information
Table 101. Teva Pharma Description and Business Overview
Table 102. Teva Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 103. Teva Pharma Hydroxycarbamide Product
Table 104. Teva Pharma Recent Development
Table 105. Cipla Corporation Information
Table 106. Cipla Description and Business Overview
Table 107. Cipla Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 108. Cipla Hydroxycarbamide Product
Table 109. Cipla Recent Development
Table 110. Zydus Cadila Corporation Information
Table 111. Zydus Cadila Description and Business Overview
Table 112. Zydus Cadila Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 113. Zydus Cadila Hydroxycarbamide Product
Table 114. Zydus Cadila Recent Development
Table 115. United Biotech Corporation Information
Table 116. United Biotech Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 117. United Biotech Description and Business Overview
Table 118. United Biotech Hydroxycarbamide Product
Table 119. United Biotech Recent Development
Table 120. Par Pharma Corporation Information
Table 121. Par Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 122. Par Pharma Description and Business Overview
Table 123. Par Pharma Hydroxycarbamide Product
Table 124. Par Pharma Recent Development
Table 125. Khandelwal Laboratories Corporation Information
Table 126. Khandelwal Laboratories Description and Business Overview
Table 127. Khandelwal Laboratories Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 128. Khandelwal Laboratories Hydroxycarbamide Product
Table 129. Khandelwal Laboratories Recent Development
Table 130. Alkem (Cytomed) Corporation Information
Table 131. Alkem (Cytomed) Description and Business Overview
Table 132. Alkem (Cytomed) Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 133. Alkem (Cytomed) Hydroxycarbamide Product
Table 134. Alkem (Cytomed) Recent Development
Table 135. Samarth Pharma Corporation Information
Table 136. Samarth Pharma Description and Business Overview
Table 137. Samarth Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 138. Samarth Pharma Hydroxycarbamide Product
Table 139. Samarth Pharma Recent Development
Table . VHB Life Sciences Corporation Information
Table . VHB Life Sciences Description and Business Overview
Table . VHB Life Sciences Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2015-2020)
Table . VHB Life Sciences Hydroxycarbamide Product
Table . VHB Life Sciences Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Hydroxycarbamide Distributors List
Table 148. Hydroxycarbamide Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Hydroxycarbamide Product Picture
Figure 2. Global Hydroxycarbamide Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hydroxycarbamide Market Share by Application in 2020 & 2026
Figure 6. Sickle Cell Disease Examples
Figure 7. Cancer Examples
Figure 8. Other Examples
Figure 9. Global Hydroxycarbamide Sales (M Units) Growth Rate (2015-2026)
Figure 10. Global Hydroxycarbamide Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Hydroxycarbamide Price Trends Growth Rate (2015-2026) (USD/K Unit)
Figure 12. Global Hydroxycarbamide Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Hydroxycarbamide Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Hydroxycarbamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Hydroxycarbamide Sales (M Units) Growth Rate (2015-2026)
Figure 16. Europe Hydroxycarbamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Hydroxycarbamide Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Hydroxycarbamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Hydroxycarbamide Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Hydroxycarbamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Hydroxycarbamide Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Hydroxycarbamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Hydroxycarbamide Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Hydroxycarbamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Hydroxycarbamide Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Hydroxycarbamide Players Market Share by Revenue in Hydroxycarbamide 2015 & 2019
Figure 27. Hydroxycarbamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Hydroxycarbamide Revenue Share by Type (2015-2020)
Figure 29. Global Hydroxycarbamide Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Hydroxycarbamide Revenue Share by Application (2015-2020)
Figure 31. Global Hydroxycarbamide Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Hydroxycarbamide Sales Market Share by Type in 2019
Figure 33. United States Hydroxycarbamide Sales Market Share by Type in 2019
Figure 34. Europe Hydroxycarbamide Sales Market Share by Company in 2019
Figure 35. Europe Hydroxycarbamide Sales Market Share by Type in 2019
Figure 36. Europe Hydroxycarbamide Sales Market Share by Application in 2019
Figure 37. China Hydroxycarbamide Sales Market Share by Company in 2019
Figure 38. China Hydroxycarbamide Sales Market Share by Type in 2019
Figure 39. China Hydroxycarbamide Sales Market Share by Application in 2019
Figure 40. Japan Hydroxycarbamide Sales Market Share by Company in 2019
Figure 41. Japan Hydroxycarbamide Sales Market Share by Type in 2019
Figure 42. Japan Hydroxycarbamide Sales Market Share by Application in 2019
Figure 43. Southeast Asia Hydroxycarbamide Sales Market Share by Company in 2019
Figure 44. Southeast Asia Hydroxycarbamide Sales Market Share by Type in 2019
Figure 45. Southeast Asia Hydroxycarbamide Sales Market Share by Application in 2019
Figure 46. India Hydroxycarbamide Sales Market Share by Company in 2019
Figure 47. India Hydroxycarbamide Sales Market Share by Type in 2019
Figure 48. India Hydroxycarbamide Sales Market Share by Application in 2019
Figure 49. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Taj Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Beijing Jialin Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Teva Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. United Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Par Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Khandelwal Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Alkem (Cytomed) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Samarth Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. VHB Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Hydroxycarbamide
Figure 64. Manufacturing Process Analysis of Hydroxycarbamide
Figure 65. Hydroxycarbamide Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
樹状細胞および腫瘍細胞がんワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stati…- 上咽頭癌治療薬の世界市場レポート2020 Market Analysis and Insights: Global Nasopharyngeal Cancer Drug Market The global Nasopharyngeal Cancer Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Nasopharyngeal Cancer Drug Scope and Market Siz…
- 生理学的測定用カプセルの世界市場レポート2020 A recently published report by QY Research titled Global Physiological Measurement Capsule Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically pr…
- 癌幹細胞（CSC）の世界市場レポート2020 Market Analysis and Insights: Global Cancer Stem Cells (CSCs) Market The global Cancer Stem Cells (CSCs) market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cancer Stem Cells (CSCs) Scope and Market Size The …
- 電子タブレット＆カプセルカウントマシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Electronic Tablet And Capsule Counting Machine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…